The U.S. Food and Drug Administration (FDA) has approved morphine sulfate extended-release tablets (Arymo ER), which is formulated with abuse-deterrent properties, for the management of pain severe enough to require daily, long-term opioid treatment for which alternative treatment options are inadequate.1
http://www.cancertherapyadvisor.com/supportive-care/cancer-chronic-pain-abuse-deterrent-morphine-treatment/article/631035/
Abuse-deterrent Morphine ER Approved for Chronic Pain